SIMAVITA LIMITED(SVA)

delisted from the close of trading on Monday, 22 February 2021, pursuant to Listing rule 17.11.

we understand the company delisted because potential partners stated a preference for it to be non-listed, improved access to capital, best interest of CDI holders, prospects for growth, low value attributed to company, illiquidity, administrative costs and large number of unmarketable parcels - the company bought back almost 1.1m shares at A$0.0185 per CDI in a capital reduction offer, payment being made on 28 January 2021

Under Listing Rule 17.6, any entity (if not already suspended) that has not paid its annual listing fees by close of business on Friday, 19 February 2021 will have its securities suspended from official quotation before the commencement of trading on Monday, 22 February 2021. The company has not paid the second instalment of its annual listing fees in respect of the year ending 30 June 2021 but the securities are already suspended from official quotation.

The securities of Simavita Limited will be suspended from quotation at the close of trading today, Thursday, 18 February 2021, in accordance with Listing Rule 17.2, pending the removal from the Official List on Monday, 22 February 2021.

The securities of Simavita Limited will be reinstated to Official Quotation immediately following the lodgement of its Statutory Accounts for the year ended 30 June 2020.

Simavita reports full year audited financial results

The company has experienced an unexpected delay in finalising its audited financial statements for the year ended 30 June 2020. The directors anticipate that the audited accounts will be finalised shortly.

The securities of the company will be suspended from Official Quotation in accordance with Listing Rule 17.5 from the commencement of trading today, 1 October 2020, following their failure to lodge the relevant periodic report by the due date.

The securities of Simavita Limited will be reinstated to Official Quotation as from the commencement of trading on Friday, 19 July 2019 following lodgement of its Appendix 4D Half Year Financial Report for the year ended 31 December 2018.

Simavita Releases HFY19 Appendix 4D and Interim Financials

The company announces the results of the Special General Meeting of the company's shareholders which was held at 10:00 am today in Sydney. All 6 resolutions that were put out before the meeting were carried by way of a poll.

Simavita releases materials for Special General Meeting for $3.075m secured notes financing. The meeting will be held at 10.00 am (AEST) on 24 June 2019 at the following address: The offices of K&L Gates Level 31, 1 O'Connell Street Sydney. New South Wales. 2000. Australia. The company has now been granted a waiver by the ASX from seeking member approval under ASX Listing Rule 10.1.

The company had secured funding commitments in aggregate of over $3 million from professional and sophisticated investors to assist it in the commercialiastion of its unique platform technology AlertPLUS focused on the USD64bn diaper industry.

Simavita releases Appendix 4C for quarter 31 March 2019

The company's securities will be suspended from official quotation following failure to lodge the relevant periodic report by the duee date.

The securities of Simavita Limited will be reinstated to official quotation as from the commencement of trading today, Thursday, 4 October 2018 following announcements regarding the completion of a placement and lodgement of its Statutory Accounts for the year ended 30 June 2018.

The company had completed a $2,975,000 financing. This was achieved by a private placement for $1.975 million and a further $1 million by way of a convertible note (subject to approval from shareholders at the 2018 Annual General Meeting). Proceeds will be used by the Company for working capital and key commercialization activities specifically focused on major markets in North America and Europe.

Simavita reports full year financial results. Total comprehensive loss after tax for the full year ended June 30, 2018 was $4.94m million, a decrease of 36% on the prior corresponding period. Total revenues for the full year were $1.10m a decrease of 41% on the prior corresponding period. Whilst revenues have decreased, expenses have decreased by a greater amount resulting in a reduction in the loss incurred by the Company. Revenues are also impacted by the expected reduction in the R&D tax incentive for the 2018 financial year due to reduced R&D expenditure incurred. The Company has developed and patented, a hyper low cost platform technology. AlertPLUSâ„¢ is focused upon a rapidly growing USD64bn per year, adult and infant diaper industry. The Company continues to progress partnership discussions with several major international diaper manufacturers based in North America and Europe. The first of these agreements was signed in August a European based global diaper manufacturer. Cash balance recorded at the end of the period was $1.36m million.

The securities of Simavita Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of SVA, pending the release of an announcement regarding a proposed placement.

The securities of Simavita Limited will be reinstated to quotation immediately, following the release of an announcement by the Company.

The company today announced that the Company, supported by its major shareholders, has completed a review of its Board, operations; executive management and working capital. With immediate effect, changes to the Board have been implemented, new funding facilities have been made available and a change to the future strategy of the Company has commenced. The Company has issued secured notes which has raised AUD$3,063,000 to assist in meeting the Company's immediate obligations and to provide a clear runway for a major restructuring of the Company's operations and implementation of a new strategy.

The securities of Simavita Limited (the "Company") will be suspended from official quotation immediately at the request of the Company, pending the release of an announcement regarding a potential capital raise and the possible changes to the composition to the Company's board of directors.

listed entity carried for record purposes only